Cargando…

Mobile-Health Tool to Improve Care of Patients with Hematological Malignancies

INTRODUCTION Adverse effects are common during treatment of hematological malignancies. Treatment toxicities can impact quality of life [1], impose financial hardship and cause cancer related distress[2]. Symptom monitoring using electronic technology can facilitate early detection of complications[...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sanyal, Amit, Heun, James M., Sweeney, Jessica, Janssen, Clemens
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society of Hematology 2020
Materias:	902.Health Services Research-Malignant Conditions (Lymphoid Disease)
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9338790/ http://dx.doi.org/10.1182/blood-2020-143405

Ejemplares similares

Outcomes in Patients with Hematological Malignancies Receiving Anti-CD20 Therapy in the Setting of COVID-19 Infection
por: Lopez, Carlos A, et al.
Publicado: (2020)

Outcomes of Adult and Pediatric Patients with Hematologic Malignancies and COVID-19: A Systematic Review and Meta-Analysis of 1847 Patients
por: Vijenthira, Abi, et al.
Publicado: (2020)

Impact of the COVID-19 Pandemic on Primary Care Access for Patients with Hematologic Malignancies
por: Ling, Ying, et al.
Publicado: (2021)

Impact of the COVID-19 Pandemic on in-Person Visit Rates Among Patients with Hematologic Malignancies in the United States
por: Goyal, Gaurav, et al.
Publicado: (2021)

A Shared Electronic Health Record in a Rural Setting Maintains Hematological Cancer Services Remotely during the COVID-19 Pandemic
por: Cashman, Helen, et al.
Publicado: (2020)

Virtual Care during the COVID-19 Pandemic Among Patients with Hematologic Malignancies - a Princess Margaret Cancer Centre Experience
por: Suleman, Adam, et al.
Publicado: (2021)

A Prospective Survey to Understand the Preferences and Perspectives of Patients with Hematological Malignancies in a Tertiary Cancer Care Setting in India (CANCOV SURVEY)
por: Sharma, Dr. Neha, et al.
Publicado: (2021)

Reduction in Transplantation Activity without Impairment in Outcomes in the Covid-19 Era- Data from the Sarah Cannon Blood Cancer Network (SCBCN)
por: Battiwalla, Minoo, et al.
Publicado: (2020)

Online Patient-Reported Platform Detects Trend of Increased COVID-19 Risk and Severity for Multiple Myeloma Patients on Active Lenalidomide-Based Therapy
por: Liu, Emily I., et al.
Publicado: (2021)

A Large London District General Hospital Highlights CLL and Bame As Risk Factors for Severe Disease Amongst Haematology-Oncology Patients
por: Farmer, Isabel, et al.
Publicado: (2020)

Prospective Pilot Study of Telehealth As Domiciliary Follow-up after Hematopoietic Cell Transplantation during the COVID19 Pandemic
por: Mussetti, Alberto, et al.
Publicado: (2020)

Worldwide Examination of Patients with CLL Hospitalized for COVID-19
por: Roeker, Lindsey E, et al.
Publicado: (2020)

Management of Indian Haematology Patients during COVID19 Crisis
por: Subash, Chezhian, et al.
Publicado: (2020)

Treating Acute Leukemia during the COVID-19 Pandemic: A Multicenter Latin American Registry
por: Demichelis, Roberta, et al.
Publicado: (2020)

The Feasibility of Virtual Toxicity Assessments in Lymphoma Patients Receiving Immunochemotherapy
por: Runge, John S., et al.
Publicado: (2020)

COVID-19 Incidence in Asymptomatic Cancer Patients Undergoing Chemotherapy
por: Monteiro, Claudia, et al.
Publicado: (2021)

Clinical Outcomes in Patients with Hematologic Malignancy (HM) and COVID-19
por: Cook, Michael Roderick, et al.
Publicado: (2020)

Outcomes in Patients with Hematologic Malignancies Infected with Sars-Cov-2: The Northwestern University Experience
por: Galvez, Carlos, et al.
Publicado: (2020)

FREQUÊNCI33DE COVID-19 ENTRE PORTADORES DE NEOPLASIAS HEMATOLÓGICAS: RESULTADOS DE PROGRAMA DE TRIAGEM AMPLA NO DECORRER DA PANDEMIA
por: Garnica, M., et al.
Publicado: (2020)

Outcomes of COVID-19 Infection in Patients with Hematologic Malignancies
por: Behrens, Elizabeth, et al.
Publicado: (2020)

Older Age and Increased Neutrophil-to-Lymphocyte Ratio (NLR) Are Predictors of Mortality in a Multiethnic Urban Cohort of Hematologic Neoplasms and COVID-19 Patients
por: D'Aiello, Angelica, et al.
Publicado: (2020)

COVID-19 in Patients with Hematologic Malignancies: A Single-Center Experience
por: Wilde, Lindsay, et al.
Publicado: (2020)

Digital Platform for Evidence-Based Medicine in Hematology (non-malignant and malignant conditions) in a Developing Country
por: Rocha, Juliana, et al.
Publicado: (2020)

Estimating Mortality in Patients with Hematological Malignancy and COVID-19: A Pooled Analysis of 10 Studies
por: Saini, Kamal S., et al.
Publicado: (2020)

Neutralizing monoclonal antibodies for early treatment of hospital‐acquired SARS‐CoV‐2 infection in hematologic patients
por: Bussini, Linda, et al.
Publicado: (2022)

The impact of prior malignancies on the development of second malignancies and survival in follicular lymphoma: A population‐based study
por: Dinnessen, Manette A.W., et al.
Publicado: (2020)

Social Media Validation for Pre-Screened Ontologies As a Driver for Biomolecular Interaction Significance in COVID-19 and Hematological Malignancies
por: Leyfman, Yan, et al.
Publicado: (2021)

COVID-19 and Hematologic Malignancies: Single Institution Analysis
por: Anusim, Nwabundo, et al.
Publicado: (2020)

Second primary malignancies in chronic lymphocytic leukaemia: Skin, solid organ, haematological and Richter's syndrome
por: Shen, Yandong, et al.
Publicado: (2021)

COVID-19 in Children, Adolescents and Young Adults with Hematological Malignancies
por: Parker, Rebecca S, et al.
Publicado: (2021)

Malignant DFFB isoform switching promotes leukemia survival in relapse pediatric T‐cell acute lymphoblastic leukemia
por: Enlund, Sabina, et al.
Publicado: (2022)

Improvement in Clinic Efficiency, Patient Satisfaction, and Overcoming Unique Challenges in the Era of COVID-19 with Implementation of Subcutaneous Daratumumab in Patients with Multiple Myeloma (MM) and Light Chain (AL) Amyloidosis
por: Hughes, David, et al.
Publicado: (2020)

Clinical features of anthracycline‐induced cardiotoxicity in patients with malignant lymphoma who received a CHOP regimen with or without rituximab: A single‐center, retrospective observational study
por: Nakayama, Takafumi, et al.
Publicado: (2020)

An Online Case-Based Clinical Elective in Hematology for Medical Students
por: Means, Robert T.
Publicado: (2020)

Success and Satisfaction with Virtual Hematology Curriculum Implemented in Response to COVID-19
por: Gunesch, Ali Noel, et al.
Publicado: (2021)

Marginal zone lymphoma expression of histidine‐rich glycoprotein correlates with improved survival
por: Persson Skare, Tor, et al.
Publicado: (2020)

The Impact of COVID-19 on Hematology-Oncology Fellowship Programs: Program Director Perspectives
por: Velazquez Manana, Ana I., et al.
Publicado: (2020)

COVID-19 Vaccine Response in Patients with Hematologic Malignancy: A Systematic Review and Meta-Analysis
por: Gong, Inna, et al.
Publicado: (2021)

Measuring the Impact of COVID-19 on Hematology-Oncology Trainees: A Quantitative and Qualitative Assessment
por: Durani, Urshila, et al.
Publicado: (2020)

Outcomes of Patients with Hematologic Malignancies and COVID-19: Perspective of a Large Hematology Center in Greece
por: Spyridis, Nikolaos, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_d7ell1h2k1evp8hoqkr2bl4m29